Back to Search
KETAN PANDYA, MD
MD
Emergency Medical Services (Emergency Medicine) Physician
NPI: 1245228733IndividualAccepts Medicare
Specialties, Licenses & Credentials
Emergency Medical Services (Emergency Medicine) PhysicianPrimary
Emergency Medicine — Emergency Medical Services
Code: 207PE0004X
ME0085671(FL)
CMS Specialties
PrimaryEMERGENCY MEDICINE
Education
NEW YORK MEDICAL COLLEGE
Class of 1998
Research & Publications (20)
Multicenter, randomized, phase 2 study of zoledronic acid in combination with docetaxel and carboplatin in patients with unresectable stage IIIB or stage IV non-small cell lung cancer.
PMID 19493585·Lung Cancer·2010
3-trial
Newer antidepressants and gabapentin for hot flashes: an individual patient pooled analysis.
PMID 19332723·J Clin Oncol·2009
8-other
Assessing persistent cancer pain: a comparison of current pain ratings and pain recalled from the past week.
PMID 18676116·J Pain Symptom Manage·2009
8-other
Guillain-Barré Syndrome with asystole requiring permanent pacemaker: a case report.
PMID 19126210·J Med Case Rep·2009
8-other
Predictors of hemodynamic compromise with propofol during defibrillator implantation: a single center experience.
PMID 19263205·J Interv Card Electrophysiol·2009
8-other
Benign skin lesions: lipomas, epidermal inclusion cysts, muscle and nerve biopsies.
PMID 19465204·Surg Clin North Am·2009
6-review
Decreased beta-adrenergic responsiveness following hypertrophy occurs only in cardiomyocytes that also re-express beta-myosin heavy chain.
PMID 19553396·Eur J Heart Fail·2009
7-preclinical
Phase 1/2 dose escalating study of twice-monthly pemetrexed and gemcitabine in patients with advanced cancer and non-small cell lung cancer.
PMID 18379358·J Thorac Oncol·2008
3-trial
Phase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinoma.
PMID 18487568·J Clin Oncol·2008
3-trial
Tumor response kinetics after schedule-dependent paclitaxel chemoradiation treatment for inoperable non-small cell lung cancer: a model for low-dose chemotherapy radiosensitization.
PMID 18520792·J Thorac Oncol·2008
3-trial
Discordant on/off switching of gene expression in myocytes during cardiac hypertrophy in vivo.
PMID 18755891·Proc Natl Acad Sci U S A·2008
7-preclinical
Toxicity profile and pharmacokinetic study of a phase I low-dose schedule-dependent radiosensitizing paclitaxel chemoradiation regimen for inoperable non-small-cell lung cancer.
PMID 18164866·Int J Radiat Oncol Biol Phys·2008
3-trial
Ni(II) complexation to amorphous hydrous ferric oxide: an X-ray absorption spectroscopy study.
PMID 17561066·J Colloid Interface Sci·2007
8-other
Phase III study of standard combination versus rotating regimen of induction chemotherapy in patients with hormone insensitive metastatic breast cancer: an Eastern Cooperative Oncology Group Intergroup Study (E3185).
PMID 17414459·Am J Clin Oncol·2007
3-trial
Design of multipulse Thomson scattering diagnostic for SST-1 tokamak.
PMID 17477660·Rev Sci Instrum·2007
8-other
A randomized, phase II trial of two dose levels of temsirolimus (CCI-779) in patients with extensive-stage small-cell lung cancer who have responding or stable disease after induction chemotherapy: a trial of the Eastern Cooperative Oncology Group (E1500).
PMID 17975496·J Thorac Oncol·2007
3-trial
Fibrosis, not cell size, delineates beta-myosin heavy chain reexpression during cardiac hypertrophy and normal aging in vivo.
PMID 17068123·Proc Natl Acad Sci U S A·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 601 E ROLLINS ST
ORLANDO, FL 32803 - Phone
- (407) 303-5600
Quick Facts
- NPI
- 1245228733
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 28
- Publications
- 20
Are you this provider?
Claim Your Profile